• Daihan Scientific signed a KRW 5.13 billion contract to supply QC analytical equipment to Daewoong Pharmaceutical Indonesia.
• The order represents 6.32% of 2025 revenue.
• The contract runs from Oct. 7, 2026, through Jan. 31, 2027; signing was completed Oct. 22, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daihan Scientific Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023900368), on October 23, 2026, and is solely responsible for the information contained therein.